Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.

Sato Y, Iwamoto J, Kanoko T, Satoh K.

Arch Intern Med. 2005 Aug 8-22;165(15):1743-8. Retraction in: JAMA Intern Med. 2016 Sep 1;176(9):1256.

PMID:
16087822
2.

Risedronate prevents hip fractures, but who should get therapy?

Deal CL.

Cleve Clin J Med. 2002 Dec;69(12):964, 968-70, 973-6. Review.

PMID:
12546269
3.

Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.

Iwamoto J, Matsumoto H, Takeda T.

Curr Med Res Opin. 2008 May;24(5):1379-84. doi: 10.1185/030079908X297321 . Epub 2008 Apr 1. Review.

PMID:
18384711
4.

Aging bone and osteoporosis: strategies for preventing fractures in the elderly.

Ettinger MP.

Arch Intern Med. 2003 Oct 13;163(18):2237-46. Review.

PMID:
14557222
5.

Risedronate: clinical usage.

Chapurlat RD, Delmas PD.

Int J Clin Pract. 2001 May;55(4):275-8. Review.

PMID:
11406915
6.

Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis.

Dougherty JA.

Ann Pharmacother. 2002 Mar;36(3):512-6. Review.

PMID:
11895066
7.

[Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures].

Netelenbos JC.

Ned Tijdschr Geneeskd. 2001 Jul 14;145(28):1336-8. Review. Dutch.

PMID:
11484428
8.
9.

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD004523.

PMID:
17636764
10.

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G.

Cochrane Database Syst Rev. 2003;(4):CD004523. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD004523.

PMID:
14584020
11.

Risedronate once a week.

White NJ, Perry CM.

Treat Endocrinol. 2003;2(6):415-20; discussion 421. Review.

PMID:
15981945
12.

The underuse of therapy in the secondary prevention of hip fractures.

Kamel HK, Duthie EH.

Drugs Aging. 2002;19(1):1-10. Review.

PMID:
11929323
13.

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women.

Kanis JA, Borgstrom F, Johnell O, Jonsson B.

Osteoporos Int. 2004 Nov;15(11):862-71. Epub 2004 Jun 3. Review.

PMID:
15175846
14.

Review of risedronate in the treatment of osteoporosis.

Geusens P, McClung M.

Expert Opin Pharmacother. 2001 Dec;2(12):2011-25. Review.

PMID:
11825332
15.
16.

Risedronate.

Goa KL, Balfour JA.

Drugs Aging. 1998 Jul;13(1):83-91; discussion 92. Review.

PMID:
9679211

Supplemental Content

Support Center